Even if you think you learned everything that you needed to know way back in biology class, everyone has knowledge gaps. And ...
KAHR Bio (KAHR or the Company), a clinical-stage biotechnology company developing DSP107, a first-in-class, bispecific 4-1BB?targeted, next-generation T-cell engager, today announced topline results ...